Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy.
about
A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancerProstate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer.Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy.
P2860
Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Recovery of serum testosterone ...... d with prostate brachytherapy.
@en
type
label
Recovery of serum testosterone ...... d with prostate brachytherapy.
@en
prefLabel
Recovery of serum testosterone ...... d with prostate brachytherapy.
@en
P2093
P2860
P356
P1476
Recovery of serum testosterone ...... d with prostate brachytherapy.
@en
P2093
Hideyasu Tsumura
Hiromichi Ishiyama
Kazumasa Matsumoto
Kazushige Hayakawa
Ken-Ichi Tabata
Masashi Kitano
Masatsugu Iwamura
Shinji Kurosaka
Shiro Baba
Shuhei Hirano
P2860
P304
P356
10.4329/WJR.V7.I12.494
P577
2015-12-01T00:00:00Z